Kilitch Drugs
Sector : Healthcare | Industry : Pharmaceuticals & Drugs
* BSE Market Depth ()
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| Total | Total | ||
Kilitch Drugs Quarterly Earnings
Kilitch Drugs quarterly & annual earnings - Track stocks financial health, Earnings performance, key metrics like revenue, net profit, and growth trends. Compare stock's quarter on quarter metrics such as revenue, net income, operating margin, and earnings per share (EPS).
More insights like Forecast, Peer comparison, latest earnings transcripts & corporate action will help to overall analyse the stock's performance . Explore trends, track growth, and gain a deeper understanding of the company's strategy and market position with every quarterly release.
Read More[+]- Financial Performance
- Results
- Forecast
- Peer Comparison
Financial Performance
| Quarter | Net Profit | YoY Change% |
|---|---|---|
| No best quarters data | ||
| Quarter | Net Profit | YoY Change% |
|---|---|---|
| No worst quarter data | ||
Earnings Forecast
Earnings reviewPro Exclusive
- Earnings Transcript
- Investor Presentations
Corporate action
- Announcements
- Board Meetings
- Bonus
- More
Frequently Asked Questions
What is the Latest Results for Kilitch Drugs (India) Ltd.
What is the net profit reported by Kilitch Drugs (India) Ltd. in Q1 FY25-26
Kilitch Drugs (India) Ltd. reported a net profit of Rs 2.
What is the Revenue Earned by Kilitch Drugs (India) Ltd.?
Kilitch Drugs (India) Ltd. reported a revenue earned of Rs 43.
What is the dividend declared in the current financial year?
Kilitch Drugs (India) Ltd. has declared a dividend of Rs 0.50 on 20 Sep, 2019.
What was the last bonus declared by Kilitch Drugs (India) Ltd.
The last bonus declared by Kilitch Drugs (India) Ltd. was on --.
What is the reported EPS & estimated EPS for Kilitch Drugs (India) Ltd.
The reported EPS for Kilitch Drugs (India) Ltd. is 16.02 and the estimated EPS is --.
What is the Latest Results for Kilitch Drugs (India) Ltd.
What is the net profit reported by Kilitch Drugs (India) Ltd. in Q1 FY25-26
Kilitch Drugs (India) Ltd. reported a net profit of Rs 2.
What is the Revenue Earned by Kilitch Drugs (India) Ltd.?
Kilitch Drugs (India) Ltd. reported a revenue earned of Rs 43.
What is the dividend declared in the current financial year?
Kilitch Drugs (India) Ltd. has declared a dividend of Rs 0.50 on 20 Sep, 2019.
What was the last bonus declared by Kilitch Drugs (India) Ltd.
The last bonus declared by Kilitch Drugs (India) Ltd. was on --.
What is the reported EPS & estimated EPS for Kilitch Drugs (India) Ltd.
The reported EPS for Kilitch Drugs (India) Ltd. is 16.02 and the estimated EPS is --.